← Back to patent-cliff list
RHNGLYOPH-0126
Tier C — Watch / tradeRHNGLYOPH-0126
Moscow Endocrine Plant
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Regional status
US
-
EU
Phase III
2026-07-08
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
When does the RHNGLYOPH-0126 patent expire?
No public expiry year is available for RHNGLYOPH-0126 yet; this page updates once verified.
How do I get a quote for RHNGLYOPH-0126 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29